⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21066160 | 0.93 | — | — | |
| SCHEMBL131101 | 0.93 | — | — | |
| SCHEMBL6661449 | 0.90 | — | — | |
| SCHEMBL21904736 | 0.89 | — | — | |
| SCHEMBL7942334 | 0.74 | RAB9A (0.35) | — | |
| SCHEMBL19932486 | 0.73 | — | — | |
| SCHEMBL13533087 | 0.72 | MGLL (0.32) | — | |
| SCHEMBL2826280 | 0.72 | MGLL (0.30) | — | |
| SCHEMBL12153360 | 0.72 | MGLL (0.30) | — | |
| SCHEMBL16300937 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3241856-B1 | POLYURETHANE CATALYST AND APPLICATION THEREOF | JIANGSU OSIC PERFORMANCE MAT CO LTD (CN) | 2021-08-18 | — | — | EP | claimed |
| EP-2824108-B1 | TETRACYCLIC ANTHRAQUINONE DERIVATIVES | TIANJIN HEMAY BIO-TECH CO LTD (CN) | 2017-04-19 | — | — | EP | claimed |
| WO-2016067271-A1 | A PROCESS FOR THE PREPARATION OF LIRAGLUTIDE | AURO PEPTIDES LTD (IN) | 2016-05-06 | — | — | WO | claimed |
| EP-1504064-B1 | PROCESS FOR PREPARING MODIFIED PIGMENTS | CABOT CORP (US) | 2010-10-20 | — | — | EP | claimed |
| EP-0971945-B1 | METHOD FOR PREPARATION OF CONJUGATE VACCINES USING URONIUM SALT | JACKSON H M FOUND MILITARY MED (US) | 2004-10-06 | — | — | EP | claimed |
| EP-3972649-B1 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| US-20260124317-A2 | Antibody Drug Conjugates | BEONE MEDICINES I GMBH (CH) | 2026-05-07 | — | — | US | disclosed |
| US-20250352659-A1 | SELF-STABILIZING LINKER CONJUGATES | BEONE MEDICINES I GMBH (CH) | 2025-11-20 | — | — | US | disclosed |
| EP-3448417-B1 | INSULIN DIMER-INCRETIN CONJUGATES | MERCK SHARP & DOHME LLC (US) | 2025-11-12 | — | — | EP | disclosed |
| US-20250339547-A1 | MET BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | NOVARTIS AG (CH) | 2025-11-06 | — | — | US | disclosed |
| US-20250295798-A1 | LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, AND MEDICAL USE THEREOF | BEIGENE SWITZERLAND GMBH (CH) | 2025-09-25 | — | — | US | disclosed |
| US-20250127907-A1 | PARP INHIBITORS | Stablix, Inc. | 2025-04-24 | — | — | US | disclosed |
| EP-1675555-A2 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OF OVERDOSE OR ABUSE | New River Pharmaceuticals Inc. (US) | 2006-07-05 | — | — | EP | disclosed |
| US-20050202565-A1 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2005-09-15 | — | — | US | disclosed |
| WO-2005032474-A2 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OF OVERDOSE OR ABUSE | NEW RIVER PHARMACEUTICALS INC. (US) | 2005-04-14 | — | — | WO | disclosed |
| EP-1181278-B1 | CYCLIC AMINE DERIVATIVES AND THEIR USES | BRISTOL MYERS SQUIBB PHARMA RE (US) | 2004-09-29 | — | — | EP | disclosed |
| EP-1181278-A1 | CYCLIC AMINE DERIVATIVES AND THEIR USES | Combichem, Inc. (US) | 2002-02-27 | — | — | EP | disclosed |
| WO-2000069820-A1 | CYCLIC AMINE DERIVATIVES AND THEIR USES | COMBICHEM, INC. (US) | 2000-11-23 | — | — | WO | disclosed |
| EP-0971945-A1 | URONIUM SALT CONJUGATE VACCINES | Lees, Andrew (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042721-A1 | URONIUM SALT CONJUGATE VACCINES | LEES ANDREW (US) | 1998-10-01 | — | — | WO | disclosed |